These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 14526374)

  • 1. Advances in Duchenne muscular dystrophy gene therapy.
    van Deutekom JC; van Ommen GJ
    Nat Rev Genet; 2003 Oct; 4(10):774-83. PubMed ID: 14526374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
    Lim LE; Rando TA
    Nat Clin Pract Neurol; 2008 Mar; 4(3):149-58. PubMed ID: 18268530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Duchenne muscular dystrophy gene therapy: shrinking the dystrophin gene.
    Roberts M; Dickson G
    Curr Opin Mol Ther; 2002 Aug; 4(4):343-8. PubMed ID: 12222872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for duchenne muscular dystrophy: expectations and challenges.
    Rodino-Klapac LR; Chicoine LG; Kaspar BK; Mendell JR
    Arch Neurol; 2007 Sep; 64(9):1236-41. PubMed ID: 17846262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy.
    Lai Y; Li D; Yue Y; Duan D
    Methods Mol Biol; 2008; 433():259-75. PubMed ID: 18679629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy.
    Duan D
    Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.
    van Deutekom JC
    Eur J Hum Genet; 2005 May; 13(5):518-9. PubMed ID: 15714219
    [No Abstract]   [Full Text] [Related]  

  • 9. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing intervention for Duchenne muscular dystrophy.
    McClorey G; Fletcher S; Wilton S
    Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
    Blankinship MJ; Gregorevic P; Chamberlain JS
    Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naked plasmid DNA for the treatment of muscular dystrophy.
    Braun S
    Curr Opin Mol Ther; 2004 Oct; 6(5):499-505. PubMed ID: 15537051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Duchenne muscular dystrophy: perspectives of treatment].
    Palmieri B; Sblendorio V
    Recenti Prog Med; 2006 Sep; 97(9):448-58. PubMed ID: 17017294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy progress and prospects: Duchenne muscular dystrophy.
    Foster K; Foster H; Dickson JG
    Gene Ther; 2006 Dec; 13(24):1677-85. PubMed ID: 17066097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
    Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
    Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efforts in Duchenne muscular dystrophy; the need for a common language between basic scientists and clinicians.
    Dubowitz V
    Neuromuscul Disord; 2004 Sep; 14(8-9):451-5. PubMed ID: 15336684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene delivery to dystrophic muscle.
    Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
    Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular therapy for duchenne muscular dystrophy].
    Takeshima Y
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():626-31. PubMed ID: 16416864
    [No Abstract]   [Full Text] [Related]  

  • 20. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase.
    Quenneville SP; Chapdelaine P; Rousseau J; Tremblay JP
    Gene Ther; 2007 Mar; 14(6):514-22. PubMed ID: 17167499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.